Article Information
History
- September 3, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- E.M. de Koff, MD1,2,
- D. van Baarle, PhD3,4,
- M.A. van Houten, PhD1,5,
- M. Reyman, PhD2,6,
- G.A.M. Berbers, PhD3,
- F. de Heij, MSc3,
- M.L.J.N. Chu, BSc2,
- E.A.M. Sanders, PhD2,3,
- D. Bogaert, PhD2,3,7,#,* and
- S. Fuentes, PhD3,#
- 1Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands
- 2Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital and University Medical Centre Utrecht, Utrecht, Netherlands
- 3Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands
- 4Department of Medical Microbiology and Infection prevention, Virology and Immunology research Group, University Medical Centre Groningen, Groningen, Netherlands
- 5Department of Paediatrics, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands
- 6Department of Dermatology, Erasmus University Medical Centre, Rotterdam, Netherlands
- 7Medical Research Council and University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK
- ↵*Corresponding author: Prof. dr. Debby Bogaert, 47 Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom, tel. +44 (0) 131 242 6352, d.bogaert{at}ed.ac.uk.
Posted September 03, 2021.
Microbiota development in early life mediates association between mode of delivery and vaccine responses
